AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Diluted EPS

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 2023231.4+43.81%
Mar 31, 2022160.9-3.42%
Mar 31, 2021166.6-35.15%
Mar 31, 2020256.9-57.76%
Mar 31, 2019608.2+53.51%
Mar 31, 2018396.2+10.08%
Mar 31, 2017359.9+29.66%
Mar 31, 2016277.6-8.21%
Mar 31, 2015302.4-24.97%
Mar 31, 2014403.1+23.94%
Mar 31, 2013325.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)